<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/acrv" ></link>
<id>urn:uuid:4164105d-f4b6-e2cc-7abb-c41531562a89</id>
<updated>2026-08-03T15:09:21-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ACRV: MILLER MARY (LO) Sold (S) 573 Shares of ACRIVON THERAPEUTICS INC for $1.76 on 7/21</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6444431" ></link>
<id>urn:uuid:3ddfba48-a0ae-36eb-ee3e-364f1ae69501</id>
<updated>2026-07-23T16:28:01-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Disposed (JS) 13,729 Shares of ACRIVON THERAPEUTICS INC for $1.79 on 5/21</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6411523" ></link>
<id>urn:uuid:1e8e31d6-bea1-e55b-1f51-fc19953368ff</id>
<updated>2026-05-26T16:09:28-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: RA CAPITAL MANAGEMENT L P (DIR,BO) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408221" ></link>
<id>urn:uuid:cf2a833d-5f22-2ea0-1d95-3d95a120057a</id>
<updated>2026-05-20T16:59:55-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: TOMSICEK MICHAEL JOHN (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408131" ></link>
<id>urn:uuid:9925260a-e403-8f82-ded2-726d79ea774b</id>
<updated>2026-05-20T16:36:35-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: SHACHAM SHARON (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408135" ></link>
<id>urn:uuid:fe6ad2ad-192f-e4eb-b220-e17680f73645</id>
<updated>2026-05-20T16:36:13-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: PALANI SANTHOSH (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408136" ></link>
<id>urn:uuid:e74df66e-8a31-cba1-49dc-ce6fee9a8655</id>
<updated>2026-05-20T16:35:52-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: MAGOVCEVIC LIEBISCH IVANA (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408139" ></link>
<id>urn:uuid:ecded951-35b8-bd7a-85ca-c05dc095d875</id>
<updated>2026-05-20T16:35:31-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: DIROCCO DEREK (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408130" ></link>
<id>urn:uuid:af3501a0-558c-8975-53f8-6d22a15e2b22</id>
<updated>2026-05-20T16:33:47-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: BAUM CHARLES M (DIR) Acquired (JB) 9,366 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408120" ></link>
<id>urn:uuid:20fef0b2-324d-da75-5bc5-ecd5dae788e4</id>
<updated>2026-05-20T16:33:03-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
<entry>
<title>ACRV: PETERSON KATHARINE (CAO) Acquired (JB) 14,227 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 5/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6408113" ></link>
<id>urn:uuid:ad82637e-d329-5ba0-996d-89e7874632fd</id>
<updated>2026-05-20T16:31:42-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.50. Mkt Cap:64.2mm. 10D Vol: 300,920]]></summary>
</entry>
</feed>